PubRank

J Whang-Peng

Author PubWeight™ 178.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 1988 4.26
2 Transformation and chromosome changes induced by Epstein-Barr virus in normal human leukocyte cultures. Proc Natl Acad Sci U S A 1969 3.72
3 Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res 1983 2.90
4 PIK3CA as an oncogene in cervical cancer. Oncogene 2000 2.75
5 Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Cancer Res 1987 2.67
6 Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22. Proc Natl Acad Sci U S A 1988 2.26
7 Chromosome translocation in peripheral neuroepithelioma. N Engl J Med 1984 2.22
8 Cytogenetic characterization of selected small round cell tumors of childhood. Cancer Genet Cytogenet 1986 2.04
9 Structure and localization of genes encoding aberrant and normal epidermal growth factor receptor RNAs from A431 human carcinoma cells. Mol Cell Biol 1985 2.02
10 Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23). Science 1982 2.02
11 Second malignancies complicating Hodgkin's disease in remission. Lancet 1975 1.90
12 Isolation of the human anionic glutathione S-transferase cDNA and the relation of its gene expression to estrogen-receptor content in primary breast cancer. Proc Natl Acad Sci U S A 1988 1.86
13 T-cell lymphoblastic lymphoma with eosinophilia associated with subsequent myeloid malignancy. Am J Surg Pathol 1992 1.69
14 Amplification of DNA sequences in human multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci U S A 1985 1.66
15 A nonrandom chromosomal abnormality, del 3p(14-23), in human small cell lung cancer (SCLC). Cancer Genet Cytogenet 1982 1.61
16 Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells. Cancer Res 1987 1.49
17 Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2'-deoxycoformycin. Proc Natl Acad Sci U S A 1984 1.46
18 Philadelphia-chromosome-positive preleukaemic state. Lancet 1972 1.33
19 Lymphoid blast crises of chronic myelogenous leukemia represent stages in the development of B-cell precursors. N Engl J Med 1983 1.32
20 Infectious mononucleosis: continuous suspension culture of peripheral blood leucocytes. Nature 1968 1.31
21 Characterization of a suppressor-cell leukemia. Evidence for the requirement of an interaction of two T cells in the development of human suppressor effector cells. N Engl J Med 1978 1.30
22 Structure of the human neutrophil elastase gene. J Biol Chem 1988 1.28
23 The human liver glutathione S-transferase gene superfamily: expression and chromosome mapping of an Hb subunit cDNA. Nucleic Acids Res 1988 1.27
24 DNA content analysis by flow cytometry and cytogenetic analysis in mycosis fungoides and Sézary syndrome. J Clin Invest 1980 1.26
25 Clinical implications of cytogenetic variants in chronic myelocytic leukemia (CML). Blood 1968 1.26
26 Hemopoietic stem cells in human peripheral blood. Science 1975 1.19
27 Studies on the antitumor activity, mechanism of action, and cell cycle effects of camptothecin. J Natl Cancer Inst 1971 1.17
28 Quality of life after curative gastrectomy for gastric cancer in a randomised controlled trial. Br J Cancer 2008 1.15
29 Hematologic and cytogenetic remission of blastic transformation in chronic granulocytic leukemia. Blood 1971 1.14
30 Refinement of lymphoma cytogenetics by the chromosome 18q21 major breakpoint region. Blood 1987 1.14
31 Reed-Sternberg cells in Hodgkin's cell lines HDLM, L-428, and KM-H2 are not actively replicating: lack of bromodeoxyuridine uptake by multinuclear cells in culture. Blood 1988 1.13
32 Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study. J Clin Oncol 1997 1.12
33 N 6 -( 2 -Isopentenyl)adenosine: the regulatory effects of a cytokinin and modified nucleoside from tRNA on human lymphocytes. Biochim Biophys Acta 1972 1.11
34 Human DNA topoisomerase I is encoded by a single-copy gene that maps to chromosome region 20q12-13.2. Proc Natl Acad Sci U S A 1988 1.11
35 Synthesis of kappa light chains by cell lines containing an 8;22 chromosomal translocation derived from a male homosexual with Burkitt's lymphoma. Science 1983 1.10
36 Prospective staging evaluation of patients with cutaneous T-cell lymphomas. Demonstration of a high frequency of extracutaneous dissemination. Ann Intern Med 1980 1.09
37 Human glutathione S-transferases. The Ha multigene family encodes products of different but overlapping substrate specificities. J Biol Chem 1988 1.09
38 Phase II and pharmacokinetic study of paclitaxel therapy for unresectable hepatocellular carcinoma patients. Br J Cancer 1998 1.06
39 Suppression of gene amplification and chromosomal DNA integration by the DNA mismatch repair system. Nucleic Acids Res 2001 1.04
40 Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer. Br J Surg 2004 1.03
41 Cross sectional study of use of alternative medicines in Chinese cancer patients. Jpn J Clin Oncol 1997 1.02
42 Human mixed leukocyte culture: identification of the proliferating lymphocyte subpopulation by sex chromosome markers. J Exp Med 1974 1.02
43 Graft-versus-host reaction complicating HL-A matched bone-marrow transplantation. Lancet 1970 1.01
44 Correlations between intercalator-induced DNA strand breaks and sister chromatid exchanges, mutations, and cytotoxicity in Chinese hamster cells. Cancer Res 1985 1.01
45 Phase II study of flutamide in the treatment of hepatocellular carcinoma. Cancer 1996 1.01
46 Cytogenetic studies in non-African Burkitt lymphoma. Blood 1980 1.01
47 Percutaneous transhepatic duodenal drainage as an alternative approach in afferent loop obstruction with secondary obstructive jaundice in recurrent gastric cancer. Cardiovasc Intervent Radiol 1998 1.01
48 Inverted repeats as genetic elements for promoting DNA inverted duplication: implications in gene amplification. Nucleic Acids Res 2001 1.01
49 Isopentenyladenosine stimulates and inhibits mitosis of human lymphocytes treated with phytohemagglutinin. Science 1969 0.99
50 Examination of human tumors for rhoA mutations. Oncogene 1994 0.98
51 Diagnostic and biological implications of flow cytometric DNA content analysis in lung cancer. Cancer Res 1983 0.97
52 Randomised clinical trial: comparison of two everolimus dosing schedules in patients with advanced hepatocellular carcinoma. Aliment Pharmacol Ther 2012 0.97
53 Transplantable hepatomas induced in strain-2 guinea pigs by diethylnitrosamine: characterization by histology, growth, and chromosomes. J Natl Cancer Inst 1969 0.96
54 Cytogenetic abnormalities in patients with cutaneous T-cell lymphomas. Cancer Treat Rep 1979 0.96
55 Retention of chromosome 3 in extrapulmonary small cell cancer shown by molecular and cytogenetic studies. J Natl Cancer Inst 1989 0.95
56 HL-A and mixed leukocyte culture matched allogeneic bone marrow transplantation in patients with acute leukemia. Transplant Proc 1971 0.93
57 Induced hyperthermia in sedated humans and the concept of critical thermal maximum. Am J Physiol 1978 0.93
58 Blast crisis of chronic granulocytic leukemia. Morphologic variants and therapeutic implications. Am J Med 1977 0.92
59 Cytogenetic studies in acute myelocytic leukemia with special emphasis on the occurrence of Ph1 chromosome. Blood 1970 0.92
60 alpha-fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma. Aliment Pharmacol Ther 2005 0.92
61 Molecular genetic characterization of neuroendocrine lung cancer cell lines. Anticancer Res 1995 0.92
62 Testicular feminization syndrome in three sibs: emphasis on gonadal neoplasia. Am J Med Sci 1973 0.91
63 S- and G2-phase cell cycle arrests and apoptosis induced by ganciclovir in murine melanoma cells transduced with herpes simplex virus thymidine kinase. Exp Cell Res 1998 0.91
64 Frequent detection of aberrant RNA transcripts of the CDKN2 gene in human gastric adenocarcinoma. Int J Cancer 1997 0.91
65 Patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. Data on potential cures, chronic toxicities, and late relapses after a five- to eleven-year follow-up. Ann Intern Med 1985 0.90
66 Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia. J Clin Invest 1992 0.90
67 Cytogenetic studies of human breast cancer lines: MCF-7 and derived variant sublines. J Natl Cancer Inst 1983 0.90
68 Identification of mutations at DNA topoisomerase I responsible for camptothecin resistance. Cancer Res 1997 0.90
69 Guinea pig leukemia L2C: characterization of chromosomes and attempts to demonstrate antigenicity. J Natl Cancer Inst 1970 0.90
70 Vaccination against gonadotropin-releasing hormone (GnRH) using toxin receptor-binding domain-conjugated GnRH repeats. Cancer Res 2000 0.89
71 Phase II study of megestrol acetate in the treatment of hepatocellular carcinoma. J Gastroenterol Hepatol 1997 0.89
72 Cytogenetically abnormal cells in vitro in acute leukaemia. Lancet 1972 0.89
73 An analysis of cytokine status in the serum and effusions of patients with tuberculous and lung cancer. Lung Cancer 2001 0.89
74 Microsatellite instability in sporadic-colon-cancer patients with and without liver metastases. Int J Cancer 1997 0.88
75 Increased fragile sites and sister chromatid exchanges in bone marrow and peripheral blood of young cigarette smokers. Cancer Res 1987 0.88
76 Burkitt's lymphoma in AIDS: cytogenetic study. Blood 1984 0.88
77 The status of the do-not-resuscitate order in Chinese clinical trial patients in a cancer centre. J Med Ethics 1999 0.88
78 Polyploidy in malignant melanoma. Cancer 1970 0.88
79 Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics. J Natl Cancer Inst 1980 0.87
80 Complication of bone-marrow transplantation. Graft-versus-host disease resulting from chronic-myelogenous-leukaemia leucocyte transfusions. Lancet 1970 0.87
81 Phase II trial of intrapleural paclitaxel injection for non-small-cell lung cancer patients with malignant pleural effusions. Respir Med 1998 0.87
82 Studies of topoisomerase-specific antitumor drugs in human lymphocytes using rabbit antisera against recombinant human topoisomerase II polypeptide. Cancer Res 1989 0.86
83 Reutilization of presumably degraded radioactive label from a chromosomal fraction of homologous and heterologous cells. Proc Soc Exp Biol Med 1967 0.86
84 Nephrotic syndrome associated with a clonal T-cell leukemia of large granular lymphocytes with cytotoxic function. Arch Intern Med 1986 0.86
85 Development of DNA delivery system using Pseudomonas exotoxin A and a DNA binding region of human DNA topoisomerase I. Appl Microbiol Biotechnol 2000 0.86
86 Leukemoid reaction resulting from multiple cytokine production in metastatic mucoepidermoid carcinoma with central necrosis. Jpn J Clin Oncol 1995 0.85
87 Stage migration influences on stage-specific survival comparison between D1 and D3 gastric cancer surgeries. Eur J Surg Oncol 2005 0.85
88 A multicenter phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (Stage IIIB/IV) non-small cell lung cancer. Chest 2000 0.85
89 Differential inducibilities of GFAP expression, cytostasis and apoptosis in primary cultures of human astrocytic tumours. Apoptosis 1998 0.85
90 Metastatic nasopharyngeal carcinoma with epidural spinal cord compression: report of an unusual and catastrophic event. Zhonghua Yi Xue Za Zhi (Taipei) 1995 0.85
91 Cross regulation by IL-10 and IL-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients. Chest 1997 0.85
92 Pulmonary embolism after transcatheter arterial chemoembolization. Eur J Cancer Care (Engl) 2005 0.85
93 Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: a randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated. Ann Oncol 2002 0.85
94 Cytogenetic studies in ovarian cancer. Cancer Genet Cytogenet 1984 0.85
95 Absence of hereditary p53 mutations in 10 familial leukemia pedigrees. J Clin Invest 1992 0.85
96 Chromosomal aberrations in two cases of inherited aplastic anemia with unusual clinical features. Ann Intern Med 1969 0.85
97 Renal cell carcinoma. Cytogenetic analysis of tumors and cell lines. Cancer Genet Cytogenet 1995 0.84
98 Peripheral neuroepithelioma: genetic analysis of tumor derived cell lines. Prog Clin Biol Res 1985 0.84
99 Elevation of interleukin-10 levels in malignant pleural effusion. Chest 1996 0.84
100 A phase I feasibility and pharmacokinetic study of intrapleural paclitaxel in patients with malignant pleural effusions. Anticancer Drugs 1997 0.84
101 A novel podophyllotoxin-derived compound GL331 is more potent than its congener VP-16 in killing refractory cancer cells. Pharm Res 1999 0.84
102 Establishment of human mesothelioma cell lines (MS-1, -2) and production of a monoclonal antibody (anti-MS) with diagnostic and therapeutic potential. Cancer Res 1988 0.83
103 Circulation of donor lymphocytes after blood transfusion in man. Blood 1977 0.83
104 The effect of daunomycin on human cells in vivo and in vitro. Cancer 1969 0.83
105 Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells. Oncol Res 1995 0.83
106 A family with acute leukemia, hypoplastic anemia and cerebellar ataxia: association with bone marrow C-monosomy. Am J Med 1978 0.83
107 Expression of epidermal growth factor receptor in head and neck cancers correlates with clinical progression: a multicentre immunohistochemical study in the Asia-Pacific region. Histopathology 2002 0.83
108 Cytogenetic studies in 45 patients with acute lymphocytic leukemia. J Natl Cancer Inst 1969 0.82
109 Cytogenetic findings in erythroleukemia. Blood 1969 0.82
110 Cytogenetic studies and clinical implications in patients with Sézary syndrome. Cancer 1976 0.82
111 Cytogenetic studies in polycythemia vera. Semin Hematol 1976 0.82
112 Serum cytokine level fluctuations in chemotherapy-induced myelosuppression. Jpn J Clin Oncol 1996 0.82
113 Cytogenetic studies of 21 patients with acute lymphoblastic leukemia in relapse. Cancer Genet Cytogenet 1989 0.82
114 Sister chromatid exchanges and chromosomes in chronic myelogenous leukemia and cancer families. Int J Cancer 1979 0.82
115 Whole body hyperthermia: a phase-I trial of a potential adjuvant to chemotherapy. Ann Intern Med 1979 0.82
116 Sister chromatid exchanges, chromosomal aberrations, and cytotoxicity produced by antitumor topoisomerase II inhibitors in sensitive (DC3F) and resistant (DC3F/9-OHE) Chinese hamster cells. Cancer Res 1988 0.82
117 In vivo incorporation of bromodeoxyuridine into proliferating cells in the marrow and its effects on granulocyte-macrophage progenitor cells. Exp Hematol 1985 0.82
118 Dicentric isochromosome for the long arm of chromosome #17, dic i(17q), in a patient with chronic myelogenous leukemia (CML). Cancer Genet Cytogenet 1981 0.81
119 Direct cytogenetic studies by needle aspiration of Burkitt's lymphoma in Ghana, West Africa. J Natl Cancer Inst 1981 0.81
120 Cytogenetic studies in acute lymphocytic leukemia: special emphasis in long-term survival. Med Pediatr Oncol 1976 0.81
121 The origin of the hematopoietic microenvironment in continuous bone marrow culture. Exp Hematol 1982 0.81
122 L2C/NB guinea pig leukemia: failure to demonstrate transmissible leukemogenic virus. Bibl Haematol 1970 0.81
123 Phase II study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapy. Lung Cancer 2000 0.80
124 Preparation of mononuclear cell subpopulations from normal human peripheral blood. Biomedicine 1977 0.80
125 Cytogenetic studies in L2C leukemia. Fed Proc 1977 0.80
126 Chemotherapy of the blastic phase of chronic granulocytic leukemia: hypodiploidy and response to therapy. Blood 1976 0.80
127 The prognostic value of serum cytokine levels in patients with acute infections. Zhonghua Yi Xue Za Zhi (Taipei) 1995 0.80
128 Multiple childhood osteosarcomas in an American Indian family with erythroid macrocytosis and skeletal anomalies. Cancer 1977 0.79
129 The significance of body weight change in non-Hodgkins lymphoma. Anticancer Res 2000 0.79
130 Non-surgical treatment for afferent loop syndrome in recurrent gastric cancer complicated by peritoneal carcinomatosis: percutaneous transhepatic duodenal drainage followed by 24-hour infusion of high-dose fluorouracil and leucovorin. Ann Oncol 2002 0.79
131 Effects of hycanthone on rapidly proliferating cells. Biochem Pharmacol 1973 0.79
132 Chromosomal instability in ataxia telangiectasia. Cancer Genet Cytogenet 1982 0.79
133 Distribution and effects of DDT in the pregnant rabbit. Xenobiotica 1972 0.79
134 Maturation and phagocytosis by chronic myelogenous leukemia cells in vitro. A preliminary report. J Natl Cancer Inst 1967 0.79
135 Cytogenetic studies in human T-cell lymphoma virus (HTLV)-positive leukemia-lymphoma in the United States. J Natl Cancer Inst 1985 0.79
136 Methodologic advances in the cytogenetic analysis of human solid tumors. Cancer Genet Cytogenet 1986 0.79
137 Clinical implications of cytogenetic studies in cutaneous T-cell lymphoma (CTCL). Cancer 1982 0.79
138 Maculopapular rashes secondary to gemcitabine injection for non-small-cell lung cancer. J Clin Oncol 1996 0.79
139 Teratogenic and cytogenetic effects of some plant-derived antitumor agents (vincristine, colchicine, maytansine, VP-16-213 and VM-26) in mice. Teratology 1978 0.78
140 Cell cycl characteristics, maturation, and phagocytosis in vitro of blast cells from patients with chronic myelocytic leukemia. Blood 1971 0.78
141 Activation of CDC 25 phosphatase and CDC 2 kinase involved in GL331-induced apoptosis. Cancer Res 1997 0.78
142 Integration of computer-assembled digital images and text data as evidence for the oncological record. J Digit Imaging 2000 0.78
143 Dicentric Ph1 chromosome. J Natl Cancer Inst 1973 0.78
144 Cytogenic studies in metastatic neuroblastoma. Am J Dis Child 1968 0.78
145 A phase II trial of vinorelbine and cisplatin in previously untreated inoperable non--small-cell lung cancer. Am J Clin Oncol 2000 0.78
146 Flowcytometric and cytogenetic analysis of human cultured cell lines derived from high- and low-grade astrocytomas. Acta Neuropathol 1983 0.78
147 Enhanced transformation of human immunocompetent cells by dibutyryl adenosine cyclic 3',5'-monophosphate. J Natl Cancer Inst 1971 0.78
148 Restoration of the immunocompetence by IL-2 activation and TCR-CD3 engagement of the in vivo anergized tumor-specific CTL from lung cancer patients. J Immunother 1997 0.78
149 A myelodysplastic syndrome with marrow eosinophilia terminating in acute nonlymphocytic leukemia, associated with an abnormal chromosome 16. Arch Pathol Lab Med 1987 0.78
150 Familial occurrence of colon and uterine carcinoma and of lymphoproliferative malignancies. II. Chromosomal and immunologic abnormalities. Cancer 1977 0.77
151 Protein tyrosine phosphatase activities are involved in apoptotic cancer cell death induced by GL331, a new homolog of etoposide. Cancer Lett 1996 0.77
152 Development of a second clonally discrete Burkitt's lymphoma in a human immunodeficiency virus-positive homosexual patient. Blood 1988 0.77
153 A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancer. Am J Clin Oncol 2000 0.77
154 Banding in leukemia: techniques and implications. J Natl Cancer Inst 1977 0.77
155 Cytogenetic effects of amsacrine on human lymphocytes in vivo and in vitro. Cancer Treat Rep 1984 0.77
156 Serial cytogenetic studies of nonendemic Burkitt's lymphoma cell lines. J Natl Cancer Inst 1980 0.77
157 In vitro evaluation of GL331's cancer cell killing and apoptosis-inducing activity in combination with other chemotherapeutic agents. Apoptosis 2000 0.77
158 Translocation of c-sis protooncogene in peripheral neuroepithelioma. Cancer Genet Cytogenet 1987 0.77
159 Epithelial origin of polyoma salivary tumors in mice: evidence based on chromosome-marked cells. Science 1971 0.77
160 Genesis of the Ph chromosome. J Natl Cancer Inst 1974 0.76
161 Chromosomal characteristics of malignant lymphoma in northern pike (Esox lucius) from the United States. Cancer Res 1976 0.76
162 Mutant lines of guinea pig L2C leukemia. II. Comparative cytogenetic studies and banding analyses of normal and leukemic karyotypes. J Natl Cancer Inst 1976 0.76
163 Karyotypic derivation of H9 cell line. J Natl Cancer Inst 1993 0.76
164 Efficacy of Re-188-labelled sulphur colloid on prolongation of survival time in melanoma-bearing animals. Nucl Med Biol 2001 0.76
165 Transcription factors and recessive oncogenes in the pathogenesis of human lung cancer. Int J Cancer Suppl 1989 0.76
166 Erythroleukemia and other hematologic complications of intensive therapy in long-term survivors of small cell lung cancer. Cancer 1982 0.76
167 Phase II study of ifosfamide and etoposide chemotherapy for extensive-disease small-cell lung cancer. Jpn J Clin Oncol 1997 0.76
168 Cytogenetics of human small cell lung cancer. Recent Results Cancer Res 1985 0.76
169 Loss of terminal deoxynucleotidyl transferase (TdT) activity as a predictor of emergence of resistance to chemotherapy in a case of chronic myelogenous leukemia in blast crisis. Cancer 1979 0.76
170 Chromosome studies in various neoplasms of domestic animals. Natl Cancer Inst Monogr 1969 0.76
171 Bone-marrow transplantation following combination chemotherapy immunosuppression (B.A.C.T.) in patients with acute leukemia. Transplant Proc 1974 0.76
172 Interleukin-7 and interleukin-12 have different effects in rescue of depressed cellular immunity: comparison of malignant and tuberculous pleural effusions. J Interferon Cytokine Res 2001 0.76
173 Evaluation of the embryotoxic activity of L-asparaginase. Arch Int Pharmacodyn Ther 1970 0.76
174 Induction of topoisomerase II gene expression in human lymphocytes upon phytohemagglutinin stimulation. Cancer Res 1990 0.76
175 An evaluation of liquid-crystal thermometry as a screening device for intraoperative hyperthermia. Anesth Analg 1979 0.75
176 A pharmacokinetic study with the high-dose anticancer agent menadione in rabbits. Biopharm Drug Dispos 1996 0.75
177 A randomised phase II study of weekly paclitaxel or vinorelbine in combination with cisplatin against inoperable non-small-cell lung cancer previously untreated. Br J Cancer 2004 0.75
178 Acute non-lymphocytic leukemia and acute myeloproliferative syndrome following radiation therapy for non-Hodgkin's lymphoma and chronic lymphocytic leukemia: cytogenetic studies. Cancer 1979 0.75
179 Acquired XO/XY clones in bone marrow of a patient with paroxysmal nocturnal hemoglobinuria (PNH). Blood 1976 0.75
180 Hyperthermia potentiates doxorubicin-related cardiotoxic effects. JAMA 1979 0.75
181 Lack of NK cells and related cytokines in pleural effusion. Zhonghua Yi Xue Za Zhi (Taipei) 1996 0.75
182 Selective toxicity of rifamycin derivatives for leukaemic human leucocytes. Nat New Biol 1972 0.75
183 Rh mosaicism and aberrant MNSs antigen expression in a patient with chronic myelogenous leukemia. Am J Clin Pathol 1983 0.75
184 Primary pulmonary malignant hemangiopericytoma associated with coagulopathy. Ann Thorac Surg 1997 0.75
185 Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer. Lung Cancer 2000 0.75
186 Elevation of serum interleukin-6 levels before peak of serum granulocyte colony-stimulating factor level in chemotherapy-induced myelosuppressive patients. J Immunother Emphasis Tumor Immunol 1995 0.75
187 Transplantation of HL-A identical allogeneic bone marrow to a patient with acute lymphocytic leukemia. Blood 1970 0.75
188 Lymphoproliferative effect of Epstein-Barr virus on normal human lymphocytes in cultures. Bibl Haematol 1970 0.75
189 Unusual clonal evolution in a case of chronic myelogenous leukemia. Acta Haematol 1976 0.75
190 The transplacental passage of fetal leukocytes into the maternal blood. Proc Soc Exp Biol Med 1973 0.75
191 Fatal hypereosinophilia with chromosome 15q- in a patient with multiple primary and familial neoplasms. Cancer Genet Cytogenet 1983 0.75
192 The atypical fluorescent body of the interphase nuclei of buccal mucosal cells and its relationship to the Y chromosome. Acta Cytol 1979 0.75
193 Additive effect of Interleukin-12 and Interleukin-18 on the T-helper cell pathway of malignant pleural effusion. Lung 2002 0.75
194 Antilymphocyte globulin as the sole immunosuppressant for bone marrow transplantation in aplastic anemia. A case report. Transplantation 1973 0.75
195 Regulation of core body temperature during whole body hyperthermia by oesophageal temperature feedback. Med Biol Eng Comput 1980 0.75
196 Ifosfamide-based chemotherapy for previously treated lung cancer patients. Zhonghua Yi Xue Za Zhi (Taipei) 1998 0.75
197 A simple, rapid, high-resolution chromosome technic for lymphocytes. Am J Clin Pathol 1983 0.75
198 Cytogenetic studies of the somatic and germ-line cells in sand rats (Psammomys obesus). Diabetologia 1970 0.75
199 Acute lymphoblastic leukemia followed by chronic myelocytic leukemia. Blood 1978 0.75
200 Anesthetic management of whole-body hyperthermia for the treatment of cancer. Anesthesiology 1980 0.75
201 Embryotoxicity in mice of phosphonacetyl-L-aspartic acid (PALA), a new antitumor agent. I. Embryolethal, teratogenic, and cytogenetic effects. Teratology 1980 0.75
202 So-called C marker chromosome and Epstein-Barr virus. J Natl Cancer Inst 1970 0.75
203 Combination chemotherapy with tamoxifen, ifosfamide, epirubicin and cisplatin in extensive-disease small-cell lung cancer. Zhonghua Yi Xue Za Zhi (Taipei) 2000 0.75
204 Lymphocytic leukaemias, acute and chronic. Clin Haematol 1980 0.75
205 Teratogenic and cytogenetic effects of hycanthone in mice and rabbits. Teratology 1974 0.75
206 Weekly CAF chemotherapy for advanced breast cancer patients. Oncology 1997 0.75
207 Causes of induced hyperthermia. Anesthesiology 1979 0.75
208 Depressed cytolytic activity of peripheral blood mononuclear cells in unusually high paclitaxel concentrations: reversal by IL-2 and IL-12. Zhonghua Yi Xue Za Zhi (Taipei) 1999 0.75
209 Erythrocyte osmotic fragility in patients receiving hyperthermia with and without chemotherapy. Cancer Treat Rep 1982 0.75
210 Chromosomes in cystic fibrosis. Lancet 1968 0.75
211 Acute megakaryoblastic leukemia in childhood. Cancer 1984 0.75
212 Elevation of serum IL-6 levels in patients with acute bacterial infection. Zhonghua Yi Xue Za Zhi (Taipei) 1995 0.75
213 Regulation of human hemopoietic stem cell proliferation by syngeneic thymus-derived lymphocytes. Acta Haematol 1977 0.75
214 Chronic granulocytic leukemia (CGL) during the course of chronic lymphocytic leukemia (CLL): correlation of blood, marrow, and spleen morphology and cytogenetics. Blood 1974 0.75
215 Bone marrow transplantation from HL-A matched donors to patients with acute leukemia. Toxicity and antileukemic effect. Transplantation 1972 0.75
216 Neurofibromatosis: no chromosomal defect by prophase banding technique. Cancer Genet Cytogenet 1984 0.75
217 The eosinophilic variant of acute myelomonocytic leukemia developing as a secondary leukemia in a patient with mycosis fungoides. Hematol Pathol 1987 0.75
218 Paclitaxel-induced severe neuropathy in patients with previous radiotherapy to the head and neck region. J Natl Cancer Inst 1996 0.75
219 RNA tumor viruses, DNA polymerases, and oncogenesis: some selective effects of rifampicin derivatives. Medicine (Baltimore) 1972 0.75
220 Myeloproliferative syndromes: a unique presentation of chronic myelogenous leukemia (CML) as a primary tumor of bone. Blood 1978 0.75
221 Continuous infusion cisplatin and etoposide chemotherapy for cancer of unknown primary site (CUPS) in Taiwan, a region with a high prevalence of endemic viral infections. Jpn J Clin Oncol 1998 0.75
222 Mitomycin-C induced hemolytic uremic syndrome: a case report and literature review. Jpn J Clin Oncol 1997 0.75
223 Prolonged cytogenetic and hematologic remission of blastic transformation in chronic granulocytic leukemia. Cancer 1972 0.75
224 Chronic granulocytic leukemia without the Philadelphia chromosome. Am J Clin Pathol 1976 0.75
225 Culture of a cell line (NCLP-6) derived from a hepatocarcinoma induced in Macaca mulatta by N-nitrosodiethylamine. J Natl Cancer Inst 1968 0.75
226 Marrow or peripheral blood for hematopoietic engraftment. N Engl J Med 1977 0.75
227 Experience with ifosfamide and etoposide combination chemotherapy in extensive-disease small-cell lung cancer. Zhonghua Yi Xue Za Zhi (Taipei) 1997 0.75
228 Paradoxical effect of GM-CSF gene transfer on the tumorigenicity and immunogenicity of murine tumors. Int J Cancer 1998 0.75
229 A phase II study of carboplatin in nasopharyngeal carcinoma. Oncology 1997 0.75